DD298423A5 - Dibenzol 1,5 dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung - Google Patents

Dibenzol 1,5 dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung Download PDF

Info

Publication number
DD298423A5
DD298423A5 DD90341537A DD34153790A DD298423A5 DD 298423 A5 DD298423 A5 DD 298423A5 DD 90341537 A DD90341537 A DD 90341537A DD 34153790 A DD34153790 A DD 34153790A DD 298423 A5 DD298423 A5 DD 298423A5
Authority
DD
German Democratic Republic
Prior art keywords
carbon atoms
formula
substituted
group
hydroxy
Prior art date
Application number
DD90341537A
Other languages
German (de)
English (en)
Inventor
Klaus Frobel
Jan-Bernd Lenfers
Peter Fey
Andreas Knorr
Johannes-Peter Stasch
Hartwig Mueller
Erwin Bischoff
Hans-Georg Dellweg
Original Assignee
�����@������������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@������������������k�� filed Critical �����@������������������k��
Publication of DD298423A5 publication Critical patent/DD298423A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/12—Eight-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/80—Penicillium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
DD90341537A 1989-06-13 1990-06-11 Dibenzol 1,5 dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung DD298423A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3919255A DE3919255A1 (de) 1989-06-13 1989-06-13 Dibenzo/1,5/dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD298423A5 true DD298423A5 (de) 1992-02-20

Family

ID=6382649

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90341537A DD298423A5 (de) 1989-06-13 1990-06-11 Dibenzol 1,5 dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung

Country Status (20)

Country Link
US (1) US5089487A (fr)
EP (1) EP0411268B1 (fr)
JP (1) JPH0324073A (fr)
KR (1) KR910000698A (fr)
CN (1) CN1048041A (fr)
AT (1) ATE121396T1 (fr)
AU (1) AU632578B2 (fr)
CA (1) CA2018659A1 (fr)
DD (1) DD298423A5 (fr)
DE (2) DE3919255A1 (fr)
DK (1) DK0411268T3 (fr)
ES (1) ES2072332T3 (fr)
FI (1) FI902901A7 (fr)
HU (2) HUT54136A (fr)
IE (1) IE902114A1 (fr)
IL (1) IL94693A0 (fr)
NO (1) NO175745C (fr)
NZ (1) NZ233989A (fr)
PT (1) PT94338A (fr)
ZA (1) ZA904524B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039860A1 (de) * 1990-12-13 1992-06-17 Bayer Ag Substituierte dibenz-oxa-thiocinone verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5198463A (en) * 1992-03-30 1993-03-30 Merck & Co., Inc. Oxytocin antagonists
JPH05280682A (ja) * 1992-04-01 1993-10-26 Kazuo Yano 屈曲自在なプラグイン・ワンタッチ接続型管継手装置
KR20010049586A (ko) * 1999-11-24 2001-06-15 윤종용 흡입마취용 식도내기관튜브
DE10250687A1 (de) * 2002-10-31 2004-05-13 Bayer Ag 7H-Dibenzo(b,g)(1,5)dioxocin-5-on-Derivate und ihre Verwendung
DE10250710A1 (de) * 2002-10-31 2004-05-19 Bayer Ag Neue Verwendung von Dioxocin-5-on-Derivaten
CN103044383B (zh) * 2011-10-17 2015-01-07 复旦大学 一种制备天然产物Penicillide消旋体的方法
CN103087040B (zh) * 2011-11-01 2015-10-28 复旦大学 Penicillide衍生物、其制备方法及其在药用用途
CN104370849A (zh) * 2014-11-13 2015-02-25 中科院广州化学有限公司 一种n-芳基二苯并氧氮杂环辛酮类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639612A (en) * 1969-05-16 1972-02-01 Lilly Co Eli Chalcogen containing heterocyclics as an in vitro anti-viral agent
US4751238A (en) * 1983-03-10 1988-06-14 Hoechst-Roussel Pharmaceuticals, Inc. Substituted alkyl amine derivatives of 6,11-dihydro-11-oxodibenz[b,e]oxepins
FR2580280B1 (fr) * 1985-04-11 1987-05-22 Synthelabo Derives d'acide dibenzo(be)oxepinne-acetique, leur preparation et leur application en therapeutique
JPH0560831B1 (fr) * 1986-06-17 1993-09-03 Dainippon Pharmaceutical Co
US4940726A (en) * 1989-04-26 1990-07-10 Arizona Board Of Regents Cell growth inhibitory macrocyclic lactones denominated Combretastatin D-1 and Combretastatin D-2
JPH04501859A (ja) * 1989-06-29 1992-04-02 アイエスケー・バイオテック・コーポレーション 新規なグリオキシレートおよびグリオキシレート活性化植物成長調整活性剤

Also Published As

Publication number Publication date
JPH0324073A (ja) 1991-02-01
CA2018659A1 (fr) 1990-12-13
IE902114A1 (en) 1991-01-02
ZA904524B (en) 1991-04-24
CN1048041A (zh) 1990-12-26
DE3919255A1 (de) 1990-12-20
HU211554A9 (en) 1995-12-28
NO902400L (no) 1990-12-14
EP0411268A2 (fr) 1991-02-06
IL94693A0 (en) 1991-04-15
NZ233989A (en) 1993-03-26
KR910000698A (ko) 1991-01-30
NO175745C (no) 1994-11-30
EP0411268A3 (en) 1991-07-03
AU632578B2 (en) 1993-01-07
HU903811D0 (en) 1990-11-28
IE902114L (en) 1990-12-13
FI902901A7 (fi) 1990-12-14
US5089487A (en) 1992-02-18
DE59008921D1 (de) 1995-05-24
PT94338A (pt) 1991-02-08
ES2072332T3 (es) 1995-07-16
EP0411268B1 (fr) 1995-04-19
DK0411268T3 (da) 1995-08-14
ATE121396T1 (de) 1995-05-15
NO175745B (no) 1994-08-22
FI902901A0 (fi) 1990-06-11
AU5600890A (en) 1990-12-20
NO902400D0 (no) 1990-05-30
HUT54136A (en) 1991-01-28

Similar Documents

Publication Publication Date Title
DE60312701T2 (de) Darstellung von 1h-imidazoä4,5-cüchinolin-4-aminen über neue 1h-imidazoä4,5-cüchinolin-4-cyano- und 1h-imidazoä4,5-cüchinolin-4-carboxamid intermediate
EP0291799B1 (fr) Dioxyalkylénaryl-dihydropyridines, procédé de préparation et composés intermédiaires ainsi que leur utilisation
EP0258729B1 (fr) Dérivés de dihydropyridines, leur procédé de préparation et leur utilisation
EP0571870A1 (fr) Cyclopentane- et -pentène-bêta-amino-acides
DE69823844T2 (de) Verfahren zur herstellung von als protease inhibitoren wervollen 4-hydroxy-2-oxo-pyran-derivaten
EP0411268B1 (fr) Dérivés de dibenzo(1,5)dioxocine-5-ones, leur usage comme médicaments et procédé pour leur préparation
EP0519291B1 (fr) 2,3-Dihydropyrano (2,3-b) pyridines amino-méthyl-substituées, procédé pour leur préparation et leur utilisation en tant que médicaments
EP0627427A1 (fr) Dihydropyridines substituées par de 3-quinolyl, procédé pour leur production et leur utilisation dans des médicaments
DE3141387A1 (de) 6-substituierte 6h-dibenzo(b,d)pyran-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE3807813A1 (de) Neue benzocycloheptenderivate, diese verbindungen enthaltende arzneimittel und verfahren zu deren herstellung
EP0586405B1 (fr) NOUVEAUX DERIVES DU 2H-BENZO[b]PYRANNE SUBSTITUES EN POSITION 4 PAR UN ARYLE OU UN N-HETEROARYLE, LEUR PROCEDE DE FABRICATION ET LEUR APPLICATION ET PREPARATIONS CONTENANT CES COMPOSES
DE4139749A1 (de) Chinolylmethoxyphenyl-essigsaeureamide
EP0738724A2 (fr) Procédé de préparation d'un dérivé N-terbutylamide
DE60315391T2 (de) Optisch aktive Epoxyverbindungen und Verfahren zu deren Herstellung
EP1373237B1 (fr) Procedes de production d'acides carboxylique d'oxirane
DE3326384A1 (de) 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE60203740T2 (de) Luminacine analoge und deren verwendung
DE2264663C3 (de) Ungesättigte Sulfoxyde und Verfahren zu ihrer Herstellung
AT381938B (de) Verfahren zur herstellung von neuen spirobenzofuranonverbindungen
AT367404B (de) Verfahren zur herstellung von neuen 1,2,3,4,4a, 10b-hexahydro-benz(f)isochinolinderivaten und ihren saeureadditionssalzen
DE19921086A1 (de) 6-Alkenyl- und 6-Alkinyl-Epothilon Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
AT350046B (de) Verfahren zur herstellung von neuen 2-phenoxy- methyl-phenoxypropionsaeurederivaten
AT358042B (de) Verfahren zur herstellung neuer 1-amino-2- -hydroxy-3-heterocyclyloxy-propane und ihrer salze
AT340922B (de) Verfahren zur herstellung von neuen tetrahydropyridinderivaten und ihren saureadditionssalzen
EP0030916B1 (fr) Carbonitriles azatétracycliques

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee